Goldman Sachs’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.56M Sell
50,000
-132,400
-73% -$10.4M ﹤0.01% 4018
2025
Q4
$15M Hold
182,400
﹤0.01% 2662
2025
Q3
$13.7M Hold
182,400
﹤0.01% 2650
2025
Q2
$13.5M Hold
182,400
﹤0.01% 2484
2025
Q1
$14.7M Buy
182,400
+132,400
+265% +$11.4M ﹤0.01% 2322
2024
Q4
$3.91M Hold
50,000
﹤0.01% 3700
2024
Q3
$4.69M Buy
+50,000
New +$4.2M ﹤0.01% 3396
2023
Q2
Sell
-4,950
Closed -$406K 5865
2023
Q1
$406K Buy
+4,950
New +$353K ﹤0.01% 4950

Other funds holding GEHC

Goldman Sachs's GEHC Position: Q1 2026 in Review

Goldman Sachs reduced its GE HealthCare (GEHC) stake by 3.3% in Q1 2026, selling an estimated $8.92M and leaving 3,266,138 shares worth $232M. The position accounts for 0.03% of the portfolio, ranked #611.

Goldman Sachs first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $277M in Q4 2025. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Goldman Sachs held 3,266,138 shares of GE HealthCare worth $232M as of Q1 2026.
  • Goldman Sachs sold 113,086 GE HealthCare shares in Q1 2026, an estimated $8.92M.
  • GE HealthCare made up 0.03% of Goldman Sachs's portfolio in Q1 2026, its #611 holding.
  • Goldman Sachs first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Goldman Sachs's GE HealthCare position peaked at $277M in Q4 2025.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.